Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets Read more
Kura Oncology Announces Positive Phase 2 Study for Tipifarnib in HRAS Mutant Head and Neck Cancer Read more
IRX Therapeutics reports positive IRX-2 phase 2a head and neck squamous cell carcinoma clinical results Read more
Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly Read more